Maxnerva Technology Services Limited Logo

Maxnerva Technology Services Limited

1037.HK

(2.0)
Stock Price

0,27 HKD

-2.73% ROA

-3.72% ROE

-9.47x PER

Market Cap.

159.369.523,31 HKD

1.29% DER

0% Yield

-2.48% NPM

Maxnerva Technology Services Limited Stock Analysis

Maxnerva Technology Services Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Maxnerva Technology Services Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.25x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (2%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

The stock's ROE falls within an average range (6.45%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (3.92%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

6 Buffet Intrinsic Value

The company's stock seems undervalued (6) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

7 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

9 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Maxnerva Technology Services Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Maxnerva Technology Services Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Maxnerva Technology Services Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Maxnerva Technology Services Limited Revenue
Year Revenue Growth
1998 539.795.435
1999 661.585.702 18.41%
2000 933.449.418 29.12%
2001 777.611.766 -20.04%
2002 820.870.120 5.27%
2003 893.858.753 8.17%
2004 1.300.933.859 31.29%
2005 1.591.921.037 18.28%
2006 1.717.341.284 7.3%
2007 1.722.033.374 0.27%
2008 1.359.883.174 -26.63%
2009 1.433.680.525 5.15%
2010 1.502.698.948 4.59%
2011 1.144.367.219 -31.31%
2012 438.803.125 -160.79%
2013 494.494.162 11.26%
2014 425.177.472 -16.3%
2015 92.824.167 -358.05%
2016 443.650.985 79.08%
2017 447.178.555 0.79%
2018 326.188.000 -37.09%
2019 430.995.000 24.32%
2019 430.995.000 0%
2020 523.417.000 17.66%
2021 596.349.000 12.23%
2022 832.461.000 28.36%
2023 1.296.248.000 35.78%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Maxnerva Technology Services Limited Research and Development Expenses
Year Research and Development Expenses Growth
1998 0
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2019 4.557.000 100%
2020 10.953.000 58.39%
2021 16.985.000 35.51%
2022 10.142.000 -67.47%
2023 23.128.000 56.15%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Maxnerva Technology Services Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1998 64.610.530
1999 66.305.675 2.56%
2000 79.786.151 16.9%
2001 69.421.482 -14.93%
2002 68.927.717 -0.72%
2003 78.448.928 12.14%
2004 99.221.358 20.94%
2005 111.336.557 10.88%
2006 121.923.443 8.68%
2007 121.354.456 -0.47%
2008 105.524.643 -15%
2009 106.652.405 1.06%
2010 95.982.352 -11.12%
2011 96.897.958 0.94%
2012 43.485.809 -122.83%
2013 65.410.308 33.52%
2014 68.341.271 4.29%
2015 31.747.187 -115.27%
2016 44.483.457 28.63%
2017 53.566.653 16.96%
2018 52.690.000 -1.66%
2019 55.028.000 4.25%
2019 50.471.000 -9.03%
2020 48.833.000 -3.35%
2021 47.091.000 -3.7%
2022 53.760.000 12.41%
2023 121.320.000 55.69%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Maxnerva Technology Services Limited EBITDA
Year EBITDA Growth
1998 -37.767.431
1999 22.228.376 269.91%
2000 28.367.843 21.64%
2001 12.453.253 -127.79%
2002 19.330.834 35.58%
2003 15.492.662 -24.77%
2004 26.138.811 40.73%
2005 34.828.915 24.95%
2006 38.435.967 9.38%
2007 36.594.757 -5.03%
2008 13.700.822 -167.1%
2009 -4.764.035 387.59%
2010 29.015.173 116.42%
2011 4.044.151 -617.46%
2012 18.848.202 78.54%
2013 14.882.810 -26.64%
2014 -19.285.349 177.17%
2015 -56.220.507 65.7%
2016 96.650.937 158.17%
2017 82.202.646 -17.58%
2018 20.805.000 -295.11%
2019 38.074.000 45.36%
2019 20.732.000 -83.65%
2020 48.890.000 57.59%
2021 41.904.000 -16.67%
2022 48.142.000 12.96%
2023 -29.844.000 261.31%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Maxnerva Technology Services Limited Gross Profit
Year Gross Profit Growth
1998 65.647.434
1999 112.178.208 41.48%
2000 136.336.324 17.72%
2001 102.683.160 -32.77%
2002 110.271.189 6.88%
2003 121.050.299 8.9%
2004 152.102.838 20.42%
2005 156.655.699 2.91%
2006 172.535.842 9.2%
2007 171.092.726 -0.84%
2008 126.508.409 -35.24%
2009 102.105.838 -23.9%
2010 130.244.709 21.6%
2011 106.073.258 -22.79%
2012 55.034.188 -92.74%
2013 70.189.700 21.59%
2014 51.654.412 -35.88%
2015 -23.340.087 321.31%
2016 152.972.949 115.26%
2017 139.815.965 -9.41%
2018 125.831.000 -11.11%
2019 77.205.000 -62.98%
2019 77.205.000 0%
2020 94.264.000 18.1%
2021 114.117.000 17.4%
2022 127.148.000 10.25%
2023 182.708.000 30.41%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Maxnerva Technology Services Limited Net Profit
Year Net Profit Growth
1998 -47.162.569
1999 21.040.057 324.16%
2000 26.133.187 19.49%
2001 10.538.836 -147.97%
2002 12.930.380 18.5%
2003 14.085.397 8.2%
2004 21.638.011 34.9%
2005 13.073.246 -65.51%
2006 10.866.765 -20.3%
2007 6.209.511 -75%
2008 6.274.142 1.03%
2009 -27.848.167 122.53%
2010 6.913.557 502.81%
2011 7.137.788 3.14%
2012 -136.953.192 105.21%
2013 6.671.632 2152.77%
2014 -31.799.893 120.98%
2015 -81.385.107 60.93%
2016 66.961.017 221.54%
2017 56.957.319 -17.56%
2018 1.440.000 -3855.37%
2019 11.575.000 87.56%
2019 11.575.000 0%
2020 14.634.000 20.9%
2021 34.261.000 57.29%
2022 27.830.000 -23.11%
2023 -90.108.000 130.89%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Maxnerva Technology Services Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1998 0
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Maxnerva Technology Services Limited Free Cashflow
Year Free Cashflow Growth
1998 70.162.396
1999 -5.212.450 1446.05%
2000 13.346.455 139.05%
2001 27.818.413 52.02%
2002 -12.122.763 329.47%
2003 7.599.231 259.53%
2004 -22.040.229 134.48%
2005 205.690 10815.27%
2006 -70.474.836 100.29%
2007 -16.603.753 -324.45%
2008 25.994.261 163.87%
2009 6.972.166 -272.83%
2010 -95.474.425 107.3%
2011 -48.683.358 -96.11%
2012 -61.726.160 21.13%
2013 -1.114.872 -5436.62%
2014 -41.952.900 97.34%
2015 -51.810.990 19.03%
2016 7.233.637 816.25%
2017 -31.858.659 122.71%
2018 -27.063.000 -17.72%
2019 18.841.250 243.64%
2019 77.452.000 75.67%
2020 50.842.000 -52.34%
2021 11.225.000 -352.94%
2022 20.323.000 44.77%
2023 61.201.000 66.79%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Maxnerva Technology Services Limited Operating Cashflow
Year Operating Cashflow Growth
1998 74.712.599
1999 6.098.906 -1125.02%
2000 30.316.278 79.88%
2001 38.196.125 20.63%
2002 -2.664.822 1533.35%
2003 21.203.503 112.57%
2004 -1.245.918 1801.84%
2005 28.957.944 104.3%
2006 -35.879.896 180.71%
2007 15.909.902 325.52%
2008 51.234.569 68.95%
2009 25.502.687 -100.9%
2010 -83.094.313 130.69%
2011 -31.436.004 -164.33%
2012 -59.118.565 46.83%
2013 2.263.332 2712.01%
2014 -37.973.510 105.96%
2015 -47.238.034 19.61%
2016 39.754.419 218.82%
2017 -28.841.326 237.84%
2018 -23.836.000 -21%
2019 20.137.000 218.37%
2019 80.548.000 75%
2020 53.016.000 -51.93%
2021 15.060.000 -252.03%
2022 22.070.000 31.76%
2023 61.660.000 64.21%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Maxnerva Technology Services Limited Capital Expenditure
Year Capital Expenditure Growth
1998 4.550.203
1999 11.311.356 59.77%
2000 16.969.822 33.34%
2001 10.377.711 -63.52%
2002 9.457.941 -9.72%
2003 13.604.272 30.48%
2004 20.794.311 34.58%
2005 28.752.254 27.68%
2006 34.594.941 16.89%
2007 32.513.655 -6.4%
2008 25.240.307 -28.82%
2009 18.530.521 -36.21%
2010 12.380.111 -49.68%
2011 17.247.354 28.22%
2012 2.607.595 -561.43%
2013 3.378.204 22.81%
2014 3.979.389 15.11%
2015 4.572.956 12.98%
2016 32.520.782 85.94%
2017 3.017.333 -977.8%
2018 3.227.000 6.5%
2019 1.295.750 -149.04%
2019 3.096.000 58.15%
2020 2.174.000 -42.41%
2021 3.835.000 43.31%
2022 1.747.000 -119.52%
2023 459.000 -280.61%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Maxnerva Technology Services Limited Equity
Year Equity Growth
1998 215.960.034
1999 253.999.565 14.98%
2000 273.451.810 7.11%
2001 284.643.977 3.93%
2002 293.234.380 2.93%
2003 298.219.146 1.67%
2004 369.162.162 19.22%
2005 371.501.197 0.63%
2006 367.137.323 -1.19%
2007 350.208.887 -4.83%
2008 339.122.042 -3.27%
2009 317.837.128 -6.7%
2010 313.041.397 -1.53%
2011 307.465.971 -1.81%
2012 170.507.555 -80.32%
2013 182.492.578 6.57%
2014 149.309.958 -22.22%
2015 216.327.332 30.98%
2016 290.472.349 25.53%
2017 328.874.000 11.68%
2018 329.654.000 0.24%
2019 343.185.000 3.94%
2020 354.793.000 3.27%
2021 412.485.000 13.99%
2022 451.033.000 8.55%
2023 436.451.000 -3.34%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Maxnerva Technology Services Limited Assets
Year Assets Growth
1998 338.231.383
1999 441.203.460 23.34%
2000 490.357.688 10.02%
2001 397.383.660 -23.4%
2002 456.791.388 13.01%
2003 502.890.738 9.17%
2004 643.266.286 21.82%
2005 708.289.246 9.18%
2006 764.561.036 7.36%
2007 730.707.503 -4.63%
2008 657.235.628 -11.18%
2009 776.457.615 15.35%
2010 732.635.450 -5.98%
2011 664.151.489 -10.31%
2012 351.254.888 -89.08%
2013 351.011.678 -0.07%
2014 284.661.235 -23.31%
2015 272.301.848 -4.54%
2016 433.061.627 37.12%
2017 509.062.000 14.93%
2018 457.425.000 -11.29%
2019 527.428.000 13.27%
2020 536.428.000 1.68%
2021 641.930.000 16.44%
2022 726.339.000 11.62%
2023 620.123.000 -17.13%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Maxnerva Technology Services Limited Liabilities
Year Liabilities Growth
1998 122.271.348
1999 187.203.894 34.69%
2000 216.905.877 13.69%
2001 112.739.681 -92.4%
2002 163.557.008 31.07%
2003 204.671.590 20.09%
2004 274.104.123 25.33%
2005 336.788.048 18.61%
2006 397.423.712 15.26%
2007 380.498.616 -4.45%
2008 318.113.585 -19.61%
2009 458.620.487 30.64%
2010 419.594.052 -9.3%
2011 356.685.517 -17.64%
2012 180.747.331 -97.34%
2013 168.519.099 -7.26%
2014 135.351.276 -24.5%
2015 55.974.515 -141.81%
2016 142.589.278 60.74%
2017 180.188.000 20.87%
2018 127.771.000 -41.02%
2019 184.243.000 30.65%
2020 181.635.000 -1.44%
2021 229.445.000 20.84%
2022 275.306.000 16.66%
2023 183.672.000 -49.89%

Maxnerva Technology Services Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.97
Net Income per Share
-0.02
Price to Earning Ratio
-9.47x
Price To Sales Ratio
0.24x
POCF Ratio
4.86
PFCF Ratio
5.1
Price to Book Ratio
0.37
EV to Sales
-0.04
EV Over EBITDA
-3.6
EV to Operating CashFlow
-0.75
EV to FreeCashFlow
-0.79
Earnings Yield
-0.11
FreeCashFlow Yield
0.2
Market Cap
0,16 Bil.
Enterprise Value
-0,02 Bil.
Graham Number
0.58
Graham NetNet
0.28

Income Statement Metrics

Net Income per Share
-0.02
Income Quality
-1.95
ROE
-0.04
Return On Assets
-0.03
Return On Capital Employed
0
Net Income per EBT
1.19
EBT Per Ebit
-17.7
Ebit per Revenue
0
Effective Tax Rate
-0.31

Margins

Sales, General, & Administrative to Revenue
0.08
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.14
Operating Profit Margin
0
Pretax Profit Margin
-0.02
Net Profit Margin
-0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.05
Free CashFlow per Share
0.04
Capex to Operating CashFlow
0.05
Capex to Revenue
0
Capex to Depreciation
0.1
Return on Invested Capital
0
Return on Tangible Assets
-0.03
Days Sales Outstanding
109.37
Days Payables Outstanding
68.9
Days of Inventory on Hand
51.97
Receivables Turnover
3.34
Payables Turnover
5.3
Inventory Turnover
7.02
Capex per Share
0

Balance Sheet

Cash per Share
0,27
Book Value per Share
0,62
Tangible Book Value per Share
0.62
Shareholders Equity per Share
0.62
Interest Debt per Share
0.01
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
-26.77
Current Ratio
2.87
Tangible Asset Value
0,43 Bil.
Net Current Asset Value
0,33 Bil.
Invested Capital
353675000
Working Capital
0,33 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,20 Bil.
Average Payables
0,11 Bil.
Average Inventory
109974500
Debt to Market Cap
0.04

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Maxnerva Technology Services Limited Dividends
Year Dividends Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2011 0 0%
2014 0 0%
2015 0 0%

Maxnerva Technology Services Limited Profile

About Maxnerva Technology Services Limited

Maxnerva Technology Services Limited, an investment holding company, operates in the industrial solution, smart office, and new retail businesses in the People's Republic of China, Europe, the United States, Taiwan, and other Asian countries. It operates through three segments: Industrial Solution Business, Smart Office Business, and New Retail Business segments. The company engages in the provision of smart manufacturing solutions and services, including the implementation of a combination of a software system, such as enterprise resources planning, manufacturing execution system, warehouse management system, etc., as well as automation equipment; the implementation of facility monitor and control systems for monitoring the efficiency of the usage of water, power, and gas to production plants; and the implementation of facial recognition systems for labor and security management of the industrial parks. It is also involved in the provision of video conferences, temperature screening access control, and digital retail signage solutions; and brand licensing and supply chain management of smart office equipment. The company was formerly known as Daiwa Associate Holdings Limited and changed its name to Maxnerva Technology Services Limited in April 2016. Maxnerva Technology Services Limited was incorporated in 1994 and is based in Tsim Sha Tsui East, Hong Kong.

CEO
Dr. Zhe Shi
Employee
272
Address
Houston Centre
Tsim Sha Tsui,

Maxnerva Technology Services Limited Executives & BODs

Maxnerva Technology Services Limited Executives & BODs
# Name Age
1 Dr. Zhe Shi
Chief Executive Officer
70
2 Mr. Chuan-Wang Chang
Executive Chairman
70
3 Dr. Hing Bun Tsang ACIS, ACS, CPA, FRM
Company Secretary
70
4 Mr. Yee Pun Cheng
Executive Director
70

Maxnerva Technology Services Limited Competitors